Ajinomoto Co., Inc. (AJINF)

OTCMKTS · Delayed Price · Currency is USD
41.50
+14.50 (53.70%)
Jul 11, 2025, 4:00 PM EDT
116.99%
Market Cap 25.62B
Revenue (ttm) 10.22B
Net Income (ttm) 469.27M
Shares Out n/a
EPS (ttm) 0.47
PE Ratio 54.59
Forward PE n/a
Dividend 24.27 (89.88%)
Ex-Dividend Date Sep 29, 2025
Volume 100
Average Volume 1,040
Open 41.50
Previous Close 27.00
Day's Range 41.50 - 41.50
52-Week Range 10.00 - 41.50
Beta 0.09
RSI 96.91
Earnings Date Aug 4, 2025

About Ajinomoto Co.

Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The Seasonings and Foods segment offers sauces and seasoning products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names; and solutions and ingredients for foodservice and processed food manufacturers, processed foods, and restaurants, as well as industrial, retail, and other applications. This segment also pr... [Read more]

Industry Packaged Foods
Founded 1909
Employees 34,860
Stock Exchange OTCMKTS
Ticker Symbol AJINF
Full Company Profile

Financial Performance

In 2024, Ajinomoto Co.'s revenue was 1.53 trillion, an increase of 6.35% compared to the previous year's 1.44 trillion. Earnings were 70.27 billion, a decrease of -19.34%.

Financial numbers in JPY Financial Statements

News

Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript

Ajinomoto Co., Inc. (OTCPK:AJINY) Q4 2025 Results Conference Call May 8, 2025 5:00 AM ETCompany ParticipantsMasataka Kaji - Investor Relations...

2 months ago - Seeking Alpha

Ajinomoto Co GAAP EPS of ¥69.77

2 months ago - Seeking Alpha

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges

PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its a...

2 months ago - Business Wire

L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co.

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Phenylalanine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been added to...

2 months ago - GlobeNewsWire

L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Alanyl-L-Glutamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been add...

2 months ago - GlobeNewsWire

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea

PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an ent...

2 months ago - Business Wire

Ajinomoto Co., Inc. (AJINY) Q2 2024 Earnings Call Transcript

Ajinomoto Co., Inc. (OTCPK:AJINY) Q2 2024 Earnings Conference Call November 7, 2024 4:00 AM ET Company Participants Masataka Kaji - Investor Relations Department Taro Fujie - Representative Executive ...

8 months ago - Seeking Alpha

Ajinomoto Co., Inc. (AJINY) Q1 2024 Earnings Call Transcript

Ajinomoto Co., Inc. (OTCPK:AJINY) Q1 2024 Earnings Conference Call August 5, 2024 4:00 AM ET Company Participants Masataka Kaji - GM Taro Fujie - Director, Representative Executive Officer, President ...

1 year ago - Seeking Alpha

Ingredients Pioneer Ajinomoto Health & Nutrition Partners with Shiru, Leveraging AI to Discover and Develop Sweet Proteins for Use in Beverages and Specialty Products

BERKELEY, Calif.--(BUSINESS WIRE)--Ajinomoto Health & Nutrition Partners with Shiru, Leveraging AI to Discover and Develop Sweet Proteins for Use in Beverages and Specialty Products.

1 year ago - Business Wire

Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium

Leveraging Advanced Manufacturing and Strict Quality Control for Superior Performance in Cellular Medicine TOKYO , March 26, 2024  /PRNewswire/ -- Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 28...

1 year ago - PRNewsWire

Essential Japanese Semi Companies For The Reshoring Age

The global COVID-19 pandemic has led to a shift towards reshoring in the semiconductor industry as supply chains are disrupted and geopolitical tensions rise. Reshoring efforts are leading to increase...

1 year ago - Seeking Alpha

Seviroli Foods Acquires a Portfolio of Italian Food Products from Ajinomoto Foods North America

GARDEN CITY, N.Y.--(BUSINESS WIRE)--Seviroli Foods LLC (“Seviroli”), a portfolio company of Mill Point Capital LLC (“Mill Point”) and a leading manufacturer of frozen pasta and other food products and...

1 year ago - Business Wire

Ajinomoto: Food, Biotech, And Semis All-In-One

Ajinomoto is diversifying its revenue segments, particularly in the biopharma and semiconductor industries, for organic growth opportunities. The company has a leading market position, high R&D invest...

1 year ago - Seeking Alpha

Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1

COLUMBUS, Ohio--(BUSINESS WIRE)--Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Forge Biologics (Forge), announced today that they have entered into a definitive agreement by which Ajinomoto Co....

1 year ago - Business Wire

Ajinomoto May Build New Factory for Chip Film

Ajinomoto says it may build an additional manufacturing base to produce more of its signature chipmaking film. Aside from its seasonings and food products, the Japanese firm also makes the Ajinomoto B...

2 years ago - Bloomberg Markets and Finance

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

TOKYO , Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce ...

2 years ago - PRNewsWire

Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer

TOKYO , Jan. 10, 2023 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreement with Exelixis, Inc. ("Exelixis") to incorporate AJICAP®, Ajinomoto Co.'s proprietary sit...

2 years ago - PRNewsWire